Production of a chimeric allergen derived from the major allergen group 1 of house dust mite species in Nicotiana benthamiana

Human Immunology

Volumn 74, Issue 5, 2013, Pages 531-537

  Li, Chaopin ^a   Jiang, Yuxin ^a   Guo, Wei ^a   Liu, Zhiming ^a  

^a WANNAN MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHIMERIC ALLERGEN R8; GAMMA INTERFERON; HERBACEOUS AGENT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PLANT MEDICINAL PRODUCT; PRODER F 1 ALLERGEN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CELL HYPERPLASIA; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; EOSINOPHIL; ESCHERICHIA COLI; FEMALE; GOBLET CELL; HOUSE DUST; LUNG PARENCHYMA; MEDICINAL PLANT; MOUSE; NICOTIANA BENTHAMIANA; NONHUMAN; PARENCHYMA; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA VIRUS; TH1 TH2 BALANCE; TOBACCO; TOVACCO MOSAIC VIRUS;

ALLERGENS; ANIMALS; ANTIBODIES; ANTIGENS, DERMATOPHAGOIDES; ARTHROPOD PROTEINS; ASTHMA; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION, IMMUNOLOGIC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VECTORS; IMMUNOGLOBULIN E; MICE; MICE, INBRED BALB C; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TOBACCO; TOBACCO MOSAIC VIRUS;

EID: 84876318983     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.01.002     Document Type: Article

References (54)

1. Takaiwa F. Seed-based oral vaccines as allergen-specific immunotherapies. Hum Vaccin 2011, 7:357-366.
2. Schmidt G., Gadermaier G., Pertl H., Siegert M., Oksman-Caldentey K.M., Ritala A., et al. Production of recombinant allergens in plants. Phytochem Rev 2008, 7:539-552.
3. Valenta R., Ferreira F., Focke-Tejkl M., Linhart B., Niederberger V., Swoboda I., et al. From allergen genes to allergy vaccines. Annu Rev Immunol 2010, 28:211-241.
4. Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nat Rev Immunol 2006, 6:869-874.
5. Lee C.C., Ho H., Lee K.T., Jeng S.T., Chiang B.L. Construction of a Der p2-transgenic plant for the alleviation of airway inflammation. Cell Mol Immunol 2011, 8:404-414.
6. Bousquet J., Lockey R., Malling H.J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998, 102:558-562.
7. Moller C., Dreborg S., Ferdousi H.A., Halken S., Host A., Jacobsen L., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002, 109:251-256.
8. Ball T., Sperr W.R., Valent P., Lidholm J., Spitzauer S., Ebner C., et al. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol 1999, 29:2026-2036.
9. Larche M., Akdis C.A., Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006, 6:761-771.
10. Moverare R., Elfman L., Vesterinen E., Metso T., Haahtela T. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and pharmacia CAP System. Allergy 2002, 57:423-430.
11. Su C.F., Kuo I.C., Chen P.W., Huang C.H., Seow S.V., Chua K.Y., et al. Characterization of an immunomodulatory Der p 2-FIP-fve fusion protein produced in transformed rice suspension cell culture. Transgenic Res 2012, 21:177-192.
12. Takaiwa F. A rice-based edible vaccine expressing multiple T-cell epitopes to induce oral tolerance and inhibit allergy. Immunol Allergy Clin North Am 2007, 27:129-139.
13. Wagner B., Fuchs H., Adhami F., Ma Y., Scheiner O., Breiteneder H. Plant virus expression systems for transient production of recombinant allergens in Nicotiana benthamiana. Methods 2004, 32:227-234.
14. Yang L., Kajiura H., Suzuki K., Hirose S., Fujiyama K., Takaiwa F. Generation of a transgenic rice seed-based edible vaccine against house dust mite allergy. Biochem Biophys Res Commun 2008, 365:334-339.
15. Yang L., Suzuki K., Hirose S., Wakasa Y., Takaiwa F. Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy. Plant Biotechnol J 2007, 5:815-826.
16. Saeki M., Nishimura T., Kaminuma O., Suzuki K., Takai T., Mori A., et al. Inhibition of allergen-induced airway inflammation by low-dose oral immunotherapy with transgenic rice seeds independently of immunoglobulin e synthesis. Int Arch Allergy Immunol 2012, 158(Suppl. 1):66-69.
17. Marconi G., Albertini E., Mari A., Palazzo P., Porceddu A., Raggi L., et al. In planta expression of a mature Der p 1 allergen isolated from an Italian strain of dermatophagoides pteronyssinus. Transgenic Res 2012, 21:523-535.
18. Suzuki K., Kaminuma O., Yang L., Motoi Y., Takai T., Ichikawa S., et al. Development of transgenic rice expressing mite antigen for a new concept of immunotherapy. Int Arch Allergy Immunol 2009, 149(Suppl. 1):21-24.
19. Suzuki K., Kaminuma O., Yang L., Takai T., Mori A., Umezu-Goto M., et al. Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression. Plant Biotechnol J 2011, 9:982-990.
20. Batard T., Didierlaurent A., Chabre H., Mothes N., Bussieres L., Bohle B., et al. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy. Int Arch Allergy Immunol 2005, 136:239-249.
21. Ferreira F., Wallner M., Breiteneder H., Hartl A., Thalhamer J., Ebner C. Genetic engineering of allergens: future therapeutic products. Int Arch Allergy Immunol 2002, 128:171-178.
22. Gomord V., Faye L. Post translational modification of therapeutic proteins in plants. Curr Opin Plant Biol 2004, 7:171-181.
23. Magi M., Garcia L., Vandenbranden M., Palmantier R., Jacquet A. Heat denaturation affects the ProDer p 1 IgE reactivity and downregulates the development of the specific allergic response. J Allergy Clin Immunol 2004, 114:545-552.
24. Schmidt M., Hoffman D.R. Expression systems for production of recombinant allergens. Int Arch Allergy Immunol 2002, 128:264-270.
25. Valenta R., Kraft D. From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol 2002, 14:718-727.
26. Daniell H., Streatfield S.J., Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 2001, 6:219-226.
27. Giddings G. Transgenic plants as protein factories. Curr Opin Biotechnol 2001, 12:450-454.
28. Kong Q., Richter L., Yang Y.F., Arntzen C.J., Mason H.S., Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 2001, 98:11539-11544.
29. McCormick A.A., Kumagai M.H., Hanley K., Turpen T.H., Hakim I., Grill L.K., et al. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc Natl Acad Sci USA 1999, 96:703-708.
30. Asturias J.A., Ibarrola I., Arilla M.C., Vidal C., Ferrer A., Gamboa P.M., et al. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy. Clin Exp Allergy 2009, 39:1088-1098.
31. Voinnet O., Rivas S., Mestre P., Baulcombe D. An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant J 2003, 33:949-956.
32. Wroblewski T., Tomczak A., Michelmore R. Optimization of Agrobacterium-mediated transient assays of gene expression in lettuce, tomato and arabidopsis. Plant Biotechnol J 2005, 3:259-273.
33. Man M., Epel B.L. Assessment of the effectiveness of a nuclear-launched TMV-based replicon as a tool for foreign gene expression in plants in comparison to direct gene expression from a nuclear promoter. Transgenic Res 2006, 15:107-113.
34. Lindbo J.A. TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector. Plant Physiol 2007, 145:1232-1240.
35. Guo W., Jiang Y.X., Li C.P. Prokaryotic expression of chimeric gene derived from the group 1 allergens of dust mites and bioactivity identification. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2012, 30:274-278.
36. Stemmer W.P. Rapid evolution of a protein in vitro by DNA shuffling. Nature 1994, 370:389-391.
37. Holsters M., de Waele D., Depicker A., Messens E., van Montagu M., Schell J. Transfection and transformation of Agrobacterium tumefaciens. Mol Gen Genet 1978, 163:181-187.
38. Chen H., Nelson R.S., Sherwood J.L. Enhanced recovery of transformants of Agrobacterium tumefaciens after freeze-thaw transformation and drug selection. Biotechniques 1994, 16(664-8):70.
39. Wydro M., Kozubek E., Lehmann P. Optimization of transient Agrobacterium-mediated gene expression system in leaves of Nicotiana benthamiana. Acta Biochim Pol 2006, 53:289-298.
40. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
41. Underwood S., Foster M., Raeburn D., Bottoms S., Karlsson J.A. Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Respir J 1995, 8:2104-2113.
42. Platts-Mills T.A., Chapman M.D. Dust mites: immunology, allergic disease, and environmental control. J Allergy Clin Immunol 1987, 80:755-775.
43. Platts-Mills T.A., Vervloet D., Thomas W.R., Aalberse R.C., Chapman M.D. Indoor allergens and asthma: report of the third international workshop. J Allergy Clin Immunol 1997, 100:2-24.
44. Sporik R., Chapman M.D., Platts-Mills T.A. House dust mite exposure as a cause of asthma. Clin Exp Allergy 1992, 22:897-906.
45. Takai T., Kato T., Sakata Y., Yasueda H., Izuhara K., Okumura K., et al. Recombinant Der p 1 and Der f 1 exhibit cysteine protease activity but no serine protease activity. Biochem Biophys Res Commun 2005, 328:944-952.
46. Thomas W.R., Smith W.A., Hales B.J., Mills K.L., O'Brien R.M. Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 2002, 129:1-18.
47. Valenta R., Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol 2007, 119:826-830.
48. Van Ree R., Antonicelli L., Akkerdaas J.H., Garritani M.S., Aalberse R.C., Bonifazi F. Possible induction of food allergy during mite immunotherapy. Allergy 1996, 51:108-113.
49. Jacquet A., Magi M., Petry H., Bollen A. High-level expression of recombinant house dust mite allergen Der p 1 in pichia pastoris. Clin Exp Allergy 2002, 32:1048-1053.
50. Chen K.W., Blatt K., Thomas W.R., Swoboda I., Valent P., Valenta R., et al. Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy. J Allergy Clin Immunol 2012, 130(435-43):e4.
51. Burtin D., Chabre H., Olagnier B., Didierlaurent A., Couret M.N., Comeau D., et al. Production of native and modified recombinant Der p 1 molecules in tobacco plants. Clin Exp Allergy 2009, 39:760-770.
52. Till S.J., Francis J.N., Nouri-Aria K., Durham S.R. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004, 113:1025-1034.
53. Fujita H., Soyka M.B., Akdis M., Akdis C.A. Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy 2012, 2:2.
54. Jutel M., Akdis C.A. Immunological mechanisms of allergen-specific immunotherapy. Allergy 2011, 66:725-732.